Cologne, Germany

Elisabeth Arkenau-Marić

This inventor holds 8 USPTO granted patents. Top assignees: Grunenthal Gmbh, Gruenenthal Gmbh. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabeth Arkenau-Marić. Retrieved from https://idiyas.com/inventor/elisabeth-arkenau-marić

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 62.5

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 486(Granted Patents)


Location History:

  • Köln, DE (2012 - 2020)
  • Cologne, DE (2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Elisabeth Arkenau-Marić: Innovator in Abuse-Proofed Dosage Forms

Introduction

Elisabeth Arkenau-Marić is a prominent inventor based in Kö'ln, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of abuse-proofed dosage forms. With a total of 8 patents to her name, her work is recognized for its innovative approach to drug formulation.

Latest Patents

One of her latest patents is a process for the production of an abuse-proofed dosage form. This invention relates to a method that incorporates one or more active ingredients with potential for abuse, along with physiologically acceptable auxiliary substances. The process utilizes at least one synthetic or natural polymer with a breaking strength of at least 500 N. Another patent details a similar process, emphasizing the importance of uniformly moistening the formulation mixture and shaping it into the desired dosage form.

Career Highlights

Elisabeth has worked with notable companies such as Grünenthal GmbH, where she has contributed her expertise in pharmaceutical innovations. Her work has been pivotal in advancing the safety and efficacy of medication delivery systems.

Collaborations

Throughout her career, Elisabeth has collaborated with esteemed colleagues, including Johannes Bartholomäus and Heinrich Kugelmann. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Elisabeth Arkenau-Marić stands out as a leading inventor in the realm of abuse-proofed dosage forms. Her contributions continue to shape the future of pharmaceutical formulations, ensuring safer medication practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…